No, not Barack Me Amadeus or John McBush.
It is time to change posting on this blog to named from anonymous. If you don't like me or my blog, you are free to say so and comments will not be removed unless outright offensive. But now I want to know who is who - even if you are using a fake name.
For the anonymous commenters that ask legit questions and make legit points and criticisms, I am sorry it has to be this way. Register with Blogger for free and let's get back to talking about markets.
The Quick Takes Pro blog by Michael Kahn, CMT about anything that might affect your portfolio.
Friday, August 29, 2008
Wednesday, August 27, 2008
Dow gets an "F"
Getting it out of the way up front, I am no economist and I only possess a basic knowledge of statistics. This does not stop me from thinking that this is a scary chart of earnings for the Dow Jones Industrial Average. I found it in a chat room and all of the attributions are listed at the bottom of this post.
What is this? It is a chart of Dow earnings since 1929 - raw, not normalized per share or per anything else. We would expect a nice rising trend with wiggles as the likes of Alcoa and McDonald's earn more money over time.
But even a statistical chowderhead like me can tell that the current reading - IF TRUE - is well outside of normal distributions. If your Grandma is invested solely in the bluest of blue chip DJIA she experienced earnings reserved for a biotech company that just failed its last hope of an FDA drug approval trial.
That cannot be a good thing for the stock market.
Here is the link to the full article by Casey Research:
http://caseyresearch.com/displayCcs.php?e=true
It looks like it used data from Barron's and was brought to the attention of the chat room by a trader named William. That's all I can pick out from his email address and I am sure he does not want his email address posted here. William, if you read this, please comment and let the world know who you are - if you like, of course.
But even a statistical chowderhead like me can tell that the current reading - IF TRUE - is well outside of normal distributions. If your Grandma is invested solely in the bluest of blue chip DJIA she experienced earnings reserved for a biotech company that just failed its last hope of an FDA drug approval trial.
That cannot be a good thing for the stock market.
Here is the link to the full article by Casey Research:
http://caseyresearch.com/displayCcs.php?e=true
It looks like it used data from Barron's and was brought to the attention of the chat room by a trader named William. That's all I can pick out from his email address and I am sure he does not want his email address posted here. William, if you read this, please comment and let the world know who you are - if you like, of course.
Subscribe to:
Posts (Atom)